Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

23.52 +0.43 (+1.86%)
Official Closing Price Updated: 7:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,199,473
Open 23.26
Bid (Size) 23.12 (1)
Ask (Size) 23.99 (1)
Prev. Close 23.09
Today's Range 23.23 - 23.58
52wk Range 20.96 - 39.09
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
5 Value Stocks In The Healthcare Sector
 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
 
Via Benzinga

Performance

YTD
-16.21%
-16.21%
1 Month
-3.96%
-3.96%
3 Month
-16.54%
-16.54%
6 Month
-0.13%
-0.13%
1 Year
-34.32%
-34.32%

More News

Read More
Organon Launches “Her Plan is Her Power,” a New Global Initiative to Reduce Unplanned Pregnancies Where Need is Great and Disparities Exist
From Organon & Co.
Via Business Wire
Organon: Dividend Insights
Via Benzinga
Why Shares of Organon Fell 15% Thursday
Via The Motley Fool
Earnings Scheduled For February 16, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Earnings Preview For Organon
Via Benzinga
Organon Reports Better Than Expected Q3 Earnings
Via Benzinga
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2022
From Organon
Via Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023
From Organon & Co.
Via Business Wire
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
Via Investor's Business Daily
'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock
Via Benzinga
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Via Investor's Business Daily
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
From Organon & Co.
Via Business Wire
Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference
From Organon & Co.
Via Business Wire
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
From Organon & Co.
Via Business Wire
3 Dow Stocks to Take Seriously in 2023
Via InvestorPlace
'FTX Users May Seek DeFi Alternatives,' Interview With Origin Protocol's Andra Nicolau
Via Benzinga
Organon To Present at the Piper Sandler 34th Annual Healthcare Conference
From Organon & Co.
Via Business Wire
10 Spin-Off Stocks That Pay Dividends
Via Talk Markets
Recap: Organon Q3 Earnings
Via Benzinga
Organon Reports Results for the Third Quarter Ended September 30, 2022
From Organon & Co.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.